Aliases & Classifications for Otitis Media

About this section

Aliases & Descriptions for Otitis Media:

Name: Otitis Media 49 10 47 12 36 2 65
Otitis Media, Susceptibility to 11
 
Infectious Otitis Media 65

Characteristics:

HPO:

61
otitis media:
Inheritance: familial predisposition


Classifications:



External Ids:

OMIM49 166760
Disease Ontology10 DOID:10754
ICD9CM29 382.9
MeSH36 D010033
NCIt42 C34885
UMLS65 C0029882, C2827407

Summaries for Otitis Media

About this section
Wikipedia:68 Otitis media is a group of inflammatory diseases of the middle ear. The two main types are acute otitis... more...

MalaCards based summary: Otitis Media, also known as otitis media, susceptibility to, is related to polycythemia and meningitis, and has symptoms including recurrent otitis media An important gene associated with Otitis Media is OMS (Otitis Media, Susceptibility To), and among its related pathways are Transcription_Role of VDR in regulation of genes involved in osteoporosis and Calcineurin-regulated NFAT-dependent transcription in lymphocytes. The drugs ceftibuten dihydrate and sulfisoxazole have been mentioned in the context of this disorder. Affiliated tissues include lung, breast and bone, and related mouse phenotypes are renal/urinary system and tumorigenesis.

Disease Ontology:10 A otitis which involves inflammation of the middle ear.

CDC:2 Español: Infección de oído

Description from OMIM:49 166760

Related Diseases for Otitis Media

About this section

Diseases related to Otitis Media via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 1030)
idRelated DiseaseScoreTop Affiliating Genes
1polycythemia30.7IL1B, TNF
2meningitis30.7IL10, IL1B, TLR2, TLR4, TNF
3porphyria30.7IL1B, TLR4, TNF
4heart disease30.6ALB, CXCL8, IL1B, TLR4
5tuberculosis30.5ALB, CD79A
6basilar artery occlusion30.5IL6, TLR4, TNF
7hemolytic anemia30.4IL10, IL6, TNF
8brain cancer30.4CXCL8, IL1B, TNF
9hyperglycemia30.4ALB, IL1B, IL6, TNF
10pulmonary edema30.4CD40LG, CD79A
11cystic echinococcosis30.4CD79A, IL1B, IL6
12obstructive sleep apnea30.3CXCL8, IL6, TNF
13purpura30.2CD40LG, CD79A
14cholera30.2IL10, IL6, TLR2, TNF
15typhus30.2CD40LG, CD79A
16motion sickness30.2CXCL8, IL6, MBL2, TNF
17optic neuritis30.2CD79A, CXCL8, IL1B, IL6
18temporal arteritis30.1CD40LG, TLR2, TLR4
19osteomalacia30.1CD40LG, CD79A
20epidermolysis bullosa simplex30.1CD40LG, CD79A
21cutaneous leishmaniasis30.1IL10, IL1B, IL6, TLR4, TNF
22obesity30.0CXCL8, IL10, IL1B, IL6, TLR2, TLR4
23membranous glomerulonephritis30.0CD40LG, CD79A, TNF
24cryoglobulinemia30.0CD40LG, CD79A, TNF
25polymyalgia rheumatica30.0CXCL8, IL6, TLR4
26angioedema30.0ALB, CD40LG, CD79A
27atopy30.0IL10, RNASE3, TLR2, TLR4
28common cold30.0CD40LG, TLR2, TLR4, TNF
29cystitis29.9CD40LG, CD79A, RNASE3
30urea cycle disorder29.8CXCL8, IL10, IL1B, IL6, TLR4, TNF
31gingival overgrowth29.8CXCL8, IL10, IL1B, IL6, MUC5B, TNF
32alcoholic liver cirrhosis29.8ALB, CXCL8, IL10, IL6, TNF
33fatty liver disease29.7ALB, CD40LG, TNF
34blastomycosis29.7ALB, CD40LG, IL10, TNF
35myocardial infarction29.5ALB, CD40LG, CXCL8, IL10, IL1B, IL6
36nasopharyngitis29.3ALB, CCL11, CXCL8, RNASE3
37systemic lupus erythematosus29.2ALB, CD40LG, CD79A, IL10, IL6, MBL2
38rheumatoid arthritis29.2CD40LG, CD79A, CXCL8, IL10, IL1B, IL6
39acalculous cholecystitis28.9CCL11, CD79A, CXCL8, IL10, MUC5B, RNASE3
40asthma28.1CCL11, CD40LG, CD79A, CXCL8, IL10, IL1B
41malaria27.9ALB, CCL11, CD40LG, CXCL8, IL10, IL1B
42suppurative otitis media12.9
43acute serous otitis media12.9
44non-suppurative otitis media12.9
45chronic purulent otitis media12.9
46purulent acute otitis media12.8
47chronic tubotympanic suppurative otitis media12.8
48acute allergic serous otitis media12.7
49acute sanguinous otitis media12.7
50acute allergic sanguinous otitis media12.7

Graphical network of the top 20 diseases related to Otitis Media:



Diseases related to otitis media

Symptoms for Otitis Media

About this section

Symptoms by clinical synopsis from OMIM:

166760

Clinical features from OMIM:

166760

HPO human phenotypes related to Otitis Media:

id Description Frequency HPO Source Accession
1 recurrent otitis media HP:0000403

Drugs & Therapeutics for Otitis Media

About this section

FDA approved drugs:

id Drug Name Active Ingredient(s)15 Company Approval Date
1
Cedax15 CEFTIBUTEN DIHYDRATE Schering-Plough December 1995
FDA Label: Cedax
Disease/s that Drug Treats:chronic bronchitis, infection of the middle ear, pharyngitis/tonsillitis
Indications and Usage:15 CEDAX (ceftibuten) is indicated for the treatment of individuals with mild-to-moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below (see DOSAGE AND ADMINISTRATION and CLINICAL STUDIES sections). Acute Bacterial Exacerbations of Chronic Bronchitis due to Haemophilus influenzae (including β-lactamase-producing strains), Moraxella catarrhalis (including β-lactamaseproducing strains), or Streptococcus pneumoniae (penicillin-susceptible strains only). NOTE: In acute bacterial exacerbations of chronic bronchitis clinical trials where Moraxella catarrhalis was isolated from infected sputum at baseline, ceftibuten clinical efficacy was 22% less than control. Acute Bacterial Otitis Media due to Haemophilus influenzae (including β-lactamase-producing strains), Moraxella catarrhalis (including β-lactamase-producing strains), or Streptococcus pyogenes. NOTE: Although ceftibuten used empirically was equivalent to comparators in the treatment of clinically and/or microbiologically documented acute otitis media, the efficacy against Streptococcus pneumoniae was 23% less than control. Therefore, ceftibuten should be given empirically only when adequate antimicrobial coverage against Streptococcus pneumoniae has been previously administered. Pharyngitis and Tonsillitis due to Streptococcus pyogenes. NOTE: Only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. Ceftibuten is generally effective in the eradication of Streptococcus pyogenes from the oropharynx; however, data establishing the efficacy of the CEDAX product for the prophylaxis of subsequent rheumatic fever are not available.
DrugBank Targets:13 Peptidoglycan synthase FtsI|Penicillin-binding protein 1A|Penicillin-binding protein 1B|Penicillin-binding protein 2
Mechanism of Action:15 
Target: -
Action: -
FDA: -

Drugs for Otitis Media (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 205)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MontelukastapprovedPhase 4, Phase 3264158966-92-85281040
Synonyms:
(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
151767-02-1 (sodium)
158966-92-8
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
AC1NQXXW
Apxi toxin
BIDD:GT0394
Brondilat
Brondilat (TN)
C07482
C35H36ClNO3S
CHEBI:50730
CHEMBL787
CID5281040
D08229
 
DB00471
HMS2089D07
HSDB 7582
LS-173539
MK 0476
MK-0476
Montair
Montelukast
Montelukast (INN)
Montelukast Sodium
Montelukast [INN:BAN]
Montelukast sodium
Montelukastum
Montélukast
Singulair
Singular
UNII-MHM278SD3E
montelukast
sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
2
AzithromycinapprovedPhase 4, Phase 3, Phase 232283905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
3
Dexamethasoneapproved, investigationalPhase 4, Phase 3, Phase 2190950-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Baycadron
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
 
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone acetate
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone sodium phosphate
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamethsone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
Ozurdex
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
4
Lansoprazoleapproved, investigationalPhase 4198103577-45-33883
Synonyms:
103577-45-3
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
A 65006
A-65006
AB00052388
ABT-006
AC1L1GX8
AG 1749
AG-1749
Abbot Brand of Lansoprazole
Agopton
Almirall Brand of Lansoprazole
Amarin
Aprazol
BIDD:GT0006
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
Bamalite
Bio-0824
Biuret
Biuret Gr
Biuret Reagent
Biuret Reagent Solution
Blason
C058687
C16H14F3N3O2S
CAS-103577-45-3
CG-4801
CHEBI:6375
CHEMBL480
CID3883
CPD000058469
Careone Lansoprazole
Compraz
D00355
DB00448
Dakar
Dg Health Lansoprazole
DivK1c_000920
EU-0100709
Equaline Lansoprazole
Equate Lansoprazole Delayed Release
Exchange Select Lansoprazole
FT-0082011
Good Neighbor Pharmacy Lansoprazole
Good Sense Lansoprazole
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS502N22
HSDB 7204
Health Mart Lansoprazole
Healthy Accents Lansoprazole
Heartburn Relief 24 Hour
Hoechst Brand of Lansoprazole
Hormona Brand of Lansoprazole
I06-0018
IDI1_000920
Ilsatec
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
Kirkland Signature Lansoprazole Delayed Release
L 8533
L8533_SIGMA
LS-33080
Lancid
Lanfast
Lanproton
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
Lansoprazole
Lansoprazole (JAN/USP/INN)
Lansoprazole Heartburn Relief 24 Hour
Lansoprazole [USAN:BAN:INN]
Lansoprazole [Usan:Ban:Inn]
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
 
Lanston
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
Lanzor
Lanzul
Lapraz
Lasoprol
Leader Lansoprazole
Lederle Brand of Lansoprazole
Limpidex
Linamarin
Lopac-L-8533
Lopac0_000709
MLS-0003247.0001
MLS000069705
MLS000759405
MLS001074170
Mesactol
MolPort-003-666-508
MolPort-006-394-760
Monolitum
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-06
NCGC00015615-11
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NINDS_000920
Ogast
Ogastro
Opiren
Preferred Plus Lansoprazole
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
PrevOnco
Prevacid
Prevacid (TN)
Prevacid 24 HR
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid SoluTab
Prevacid Solutab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
Prevpac
Prezal
Pro Ulco
Promeco
Promeco Brand of Lansoprazole
Promp
Prosogan
Rugby Heartburn Treatment
S1354_Selleck
SAM001246544
SMR000058469
SPBio_000488
SPBio_002992
SPECTRUM1503926
STK621169
Salvar Brand of Lansoprazole
Shoprite Lansoprazole
Simply Right Lansoprazole
Smart Sense Acid Reducer
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
Spectrum_001580
Sunmark Lansoprazole
Suprecid
TAK 390MR
TAK-390MR
TAK390MR
TAP Brand of Lansoprazole
TL8000155
Takeda Brand of Lansoprazole
Takepron
Tecnobio Brand of Lansoprazole
Topcare Lansoprazole
UNII-0K5C5T2QPG
Ulpax
Vinas Brand of Lansoprazole
Well At Walgreens Lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton
lansoprazole
lansoprazole sulphone
lanzoprazole
5
Ciprofloxacinapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 121285721-33-12764
Synonyms:
1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O
1-Cyclopropyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
17850_FLUKA
3-Quinolinecarboxylic acid,1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)
33434_FLUKA
33434_RIEDEL
85721-33-1
AC-7613
AC1L1EEW
AKOS000269653
ARONIS020379
Alcon Cilox
BAS 06989041
BAY q 3939
BAY-Q-3939
BAYQ3939
BIDD:GT0205
BPBio1_000140
BRD-K04804440-311-02-3
BRN 3568352
BSPBio_000126
BSPBio_003344
Bacquinor
Baflox
Bay o 9867
Bay o 9867 (*Hydrochloride*)
Bay-09867
Baycip
Bernoflox
Bi-Cipro
Bio-0540
C05349
C17H18FN3O3
CAS-93107-08-5
CBMicro_048498
CCRIS 5241
CHEBI:100241
CHEMBL8
CID2764
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
CPF
CPFX
CRL-1605 & Ciprofloxacin
Ciflox
Cifloxin
Cilab
Ciloxan
Ciloxan (*Hydrochloride*)
Ciplus
Ciprecu
Ciprinol
Cipro
Cipro (*Hydrochloride*)
Cipro (TN)
Cipro I.V.
Cipro IV
Cipro XL
Cipro XR
Ciprobay
Ciprobay Uro
Ciprocinol
Ciprodar
Ciproflox
Ciprofloxacin
Ciprofloxacin (JAN/USP/INN)
Ciprofloxacin Extended-Release
Ciprofloxacin HCl
Ciprofloxacin Hydrchloride
Ciprofloxacin Hydrochloride
Ciprofloxacin Otic
Ciprofloxacin [USAN:INN:BAN]
Ciprofloxacin dihydrochloride
Ciprofloxacin hydrochloride
Ciprofloxacin monohydrochloride
Ciprofloxacina
Ciprofloxacine
Ciprofloxacine [INN-French]
 
Ciprofloxacino
Ciprofloxacino [INN-Spanish]
Ciprofloxacinum
Ciprofloxacinum [INN-Latin]
Ciprogis
Ciprolin
Ciprolon
Cipromycin
Ciproquinol
Ciprowin
Ciproxan
Ciproxin
Ciproxina
Ciproxine
Ciriax
Citopcin
Cixan
Corsacin
Cycin
Cyprobay
D00186
DB00537
DivK1c_000095
Eni
Fimoflox
Flociprin
Floxin
HMS1922E18
HMS2090O07
HMS2093I03
HMS500E17
HSDB 6987
IDI1_000095
Ipiflox
Italnik
KBio1_000095
KBio2_000642
KBio2_003210
KBio2_005778
KBio3_002846
KBioGR_001567
KBioSS_000642
LS-141563
Liposomal-ciprofloxacin
Loxan
MLS001336035
MolPort-000-819-654
NCGC00016959-01
NCGC00095058-01
NCGC00095058-02
NCGC00178128-01
NINDS_000095
NSC620634
Ocuflox
Oprea1_008239
Oprea1_313572
Prestwick0_000113
Prestwick1_000113
Prestwick2_000113
Prestwick3_000113
Probiox
Proflaxin
Proflox
Proksi 250
Proksi 500
Proquin XR
Quinolid
Quintor
Rancif
Roxytal
SMP1_000125
SMR000471901
SPBio_001474
SPBio_002065
SPECTRUM1503614
STK021082
Septicide
Sophixin Ofteno
Spectrum2_001567
Spectrum3_001872
Spectrum4_000874
Spectrum5_001089
Spectrum_000162
Spitacin
Superocin
UNII-5E8K9I0O4U
Unex
Velomonit
Zumaflox
ciprofloxacin
nchembio820-comp1
6
Fentanylapproved, illicit, investigationalPhase 4, Phase 2, Phase 3705437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Abstral
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl - Novaplus
Fentanyl Citrate
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
 
Fentanyl-12
Fentanyl-25
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Lazanda
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
Subsys
UNII-UF599785JZ
fentanyl
7
OseltamivirapprovedPhase 4, Phase 393204255-11-865028
Synonyms:
(-)-Oseltamivir
(-)-oseltamivir
(3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid
(3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid
(−)-oseltamivir
196618-13-0
204255-11-8
4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid
AC1L22FK
AC1Q63H0
Agucort
Agucort (TN)
BIDD:GT0426
BRD-K76011241-045-01-5
C08092
CHEBI:7798
CHEMBL1229
CID65028
D08306
DB00198
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate
FT-0082384
 
GS 4104
GS-4104
GS4104
HMS2090C11
HSDB 7433
LS-57422
MolPort-005-933-026
NCGC00178698-01
Oseltamivir
Oseltamivir (INN)
Oseltamivir [INN:BAN]
Oseltamivir phosphate
Oseltamivirum
Ro-64-0796
Ro-640796
Tamiflu
Tamiflu (*Phosphate salt 1:1*)
Tamiflu-Free
Tamvir
UNII-20O93L6F9H
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate
oseltamivir
oseltamivirum
8
CefdinirapprovedPhase 4, Phase 2, Phase 32391832-40-56915944
Synonyms:
(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-hydroxyimino]-acetylamino}-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R,Z)-7-(2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid
7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
91832-40-5
AC1OCD3C
BIDD:GT0827
BMY 28488
BSPBio_002735
C08110
C14H13N5O5S2
CFDN
CHEBI:3485
CHEMBL927
CI 983
CI-983
CID6915944
Cefdinir
Cefdinir (JP15/USAN/INN)
Cefdinir [USAN:INN]
Cefdinirum
 
Cefdinirum [INN-Latin]
Cefdinyl
Cefdirnir
Cefzon
Cefzon (TN)
D00917
DB00535
FK 482
FK-482
FR-80482
HMS1922L19
HMS2093K20
KS-1038
LS-149988
MolPort-002-885-812
NCGC00178499-01
Omnicef
Omnicef (TN)
Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir
PD 134393
PD-134393
S1605_Selleck
SPECTRUM1505208
Spectrum5_001560
UNII-CI0FAO63WC
cefdinir
9
Morphineapproved, investigationalPhase 485557-27-25288826
Synonyms:
(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(-)-Heroin hydrochloride
(-)-Morphine
(-)Morphine sulfate
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL
(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
(−)-morphine
17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol
4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol
4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol
47106-99-0
57-27-2
6211-15-0 (sulfate (2:1) (salt) pentahydrate)
64-31-3
64-31-3 (sulfate (2:1) (salt) anhydrous)
7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol
7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
8053-16-5
85201-37-2
Apokyn
Astramorph PF
Avinza
BIDD:GT0147
C01516
CCRIS 5762
CHEBI:17303
CHEMBL70
CID5288826
Cube juice
D-(-)-Morphine
DB00295
DEA No. 9300
DepoDur
Depodur
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dolcontin
Dreamer
Dulcontin
Duramorph
Duramorph PF
Duromorph
EINECS 200-320-2
Epimorph
HSDB 2134
Hard stuff
Heroin hydrochloride
Heroine hydrochloride
Hocus
Infumorph
 
Kadian
LS-91748
M-Eslon
M.O.S
MOI
MORPHINE SULFATE
MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE
MS Contin
MS/L
MS/S
MSIR
Meconium
MolPort-003-849-273
Morfina
Morfina [Italian]
Morphia
Morphin
Morphin [German]
Morphina
Morphina [Italian]
Morphine
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine Sulfate
Morphine [BAN]
Morphinism
Morphinum
Morphitec
Morphium
Morpho
Moscontin
Ms Contin
Ms Emma
NSC11441
Nepenthe
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
Oramorph SR
Ospalivina
RMS
RMS Uniserts
Rescudose
Roxanol
Roxanol 100
Roxanol UD
SDZ 202-250
SDZ202-250
Statex
Statex Drops
Statex SR
UNII-76I7G6D29C
Unkie
l-Morphine
morphine
nchembio.317-comp1
nchembio.64-comp1
10
AmoxicillinapprovedPhase 4, Phase 3, Phase 239126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Extended-release
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
Augmentinxr
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
 
BRL-2333
BSPBio_000453
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
11
KetorolacapprovedPhase 427866635-83-43826
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
(+-)-isomer
(.+/-.)-2,3-Dihydro-5-benzoyl-1H-pyrrolizine-1-carboxylic acid
1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro
5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
5-Benzoyl-1,2-dihydro-3H-pyrrolo(1,2a)pyrrole-1-carboxylic acid
5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
66635-83-4
74103-06-3
AB00053682
AC-545
AC1L1GSW
Acular
Acuvail
BRD-A40639672-234-05-7
C07062
CHEBI:105080
CHEMBL469
CID3826
D020910
D08104
DB00465
 
I14-2832
Ketoralac
Ketorolac
Ketorolac (INN)
Ketorolac Tromethamine
Ketorolac [INN:BAN]
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
Kétorolac
LS-139094
Macril
MolPort-005-933-093
NCGC00185990-01
RS 37619
RS-37619
SBB067312
STL018674
Sprix
Toradol (TN)
UNII-YZI5105V0L
ketorolac
rac-Ketorolac
12
HalofantrineapprovedPhase 41769756-53-237393
Synonyms:
(+-)-Halofantrine hydrochloride
(1)-Halofantrine
1,3-Dichloro-.alpha.-[2-(dibutylamino)ethyl]-6- (trifluoromethyl)-9-phenathrenemethanol
1,3-Dichloro-.alpha.-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-9-phenanthrene-methanol
1,3-Dichloro-6-trifluoromethyl-9-(3-(dibutylamino)-1-hydroxypropyl)phenanthrene HCl
1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol hydrochloride
1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)phenanthren-1-methanol hydrochloride
1-(1,3-Dichloro-6-trifluoromethyl-9-phenanthryl)-3-(di-n-butylamino)propanol hydrochloride
1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol HCl
106927-11-1
3-(Dibutylamino)-1-(1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl)propan-1-ol hydrochloride
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol hydrochloride
36167-63-2
66051-63-6
69756-53-2
9-(3-(dibutylamino)-1-hydroxypropyl)-1,3-dichloro-6-(trifluoromethyl)phenanthrene hydrochloride
9-Phenanthrenemethanol, 1,3-dichloro-.alpha.-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-(1)
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, hydrochloride
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-,hydrochloride
AB00514703
AC-481
AC1L1XMK
AC1L1XMN
AC1Q4K45
BPBio1_001366
BSPBio_001241
C26H30Cl2F3NO.HCl
CHEBI:252728
CHEMBL1107
CHEMBL1200901
CID37392
CID37393
D02485
DB01218
EINECS 252-895-4
FT-0082696
 
HALOFANTRINE HYDROCHLORIDE
HMS1571O03
Halfan
Halfan (TN)
Halofantrina
Halofantrina [INN-Spanish]
Halofantrine
Halofantrine HCl
Halofantrine Hydrochloride [USAN]
Halofantrine [USAN]
Halofantrine [Usan]
Halofantrine hydrochloride (USAN)
Halofantrino
Halofantrino [Spanish]
Halofantrinum
Halofantrinum [INN-Latin]
I14-2822
LS-102675
LS-187198
MLS002154111
MolPort-005-940-418
MolPort-005-942-171
NCGC00179250-01
NCI60_002593
Prestwick0_001031
Prestwick1_001031
Prestwick2_001031
Prestwick3_001031
SK&F-102866
SMR001233418
SPBio_003092
UNII-H77DL0Y630
UNII-Q2OS4303HZ
WR 171,699
WR 171669
WR-171,669
WR-171669
WR-171699
dl-WR 171669
13
AcetylcysteineapprovedPhase 4293616-91-112035
Synonyms:
(2R)-2-acetylamino-3-Sulfanylpropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoic acid
(R)-Mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
 
Fluprowit
L-Acetylcysteine
L-alpha-acetamido-beta-Mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-ACETYL-L-cysteine
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
14Antirheumatic AgentsPhase 4, Phase 28496
15Analgesics, Non-NarcoticPhase 4, Phase 2, Phase 35184
16BCG VaccinePhase 499
17Adjuvants, ImmunologicPhase 41783
18Immunologic FactorsPhase 4, Phase 3, Phase 1, Phase 218483
19Antitubercular AgentsPhase 4, Phase 3, Phase 11061
20Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 28478
21Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 23549
22AntiemeticsPhase 4, Phase 3, Phase 23213
23glucocorticoidsPhase 4, Phase 3, Phase 23896
24Dexamethasone acetatePhase 4, Phase 3, Phase 219091177-87-3
25HIV Protease InhibitorsPhase 4, Phase 34558
26Protease InhibitorsPhase 4, Phase 34558
27Topoisomerase InhibitorsPhase 4, Phase 3, Phase 2, Phase 14081
28Protective AgentsPhase 4, Phase 35651
29Dexamethasone 21-phosphatePhase 4, Phase 3, Phase 21909
30Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 3, Phase 23036
31Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 24256
32Antiviral AgentsPhase 4, Phase 38071
33AntioxidantsPhase 4, Phase 32442
34BB 1101Phase 4, Phase 3, Phase 21909
35Cytochrome P-450 CYP1A2 InhibitorsPhase 4, Phase 3, Phase 2460
36Pharmaceutical SolutionsPhase 4, Phase 3, Phase 27004
37Aluminum phosphatePhase 4, Phase 1, Phase 230
38Respiratory System AgentsPhase 43931
39Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 218510
40Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 29988
41Antibiotics, AntitubercularPhase 4, Phase 35971
42Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 1, Phase 2440
43AntacidsPhase 41453
44VaccinesPhase 4, Phase 3, Phase 1, Phase 26085
45HormonesPhase 4, Phase 3, Phase 211748
46Hormone AntagonistsPhase 4, Phase 3, Phase 210002
47Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 19140
48Amoxicillin-Potassium Clavulanate CombinationPhase 4, Phase 3, Phase 2121
49Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 117220
50Beta-Lactamase InhibitorsPhase 4, Phase 3, Phase 2245

Interventional clinical trials:

(show top 50)    (show all 222)
idNameStatusNCT IDPhase
1Acute Otitis Media (AOM) Therapy Trial in Young ChildrenCompletedNCT00377260Phase 4
2A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in ChildrenCompletedNCT00189462Phase 4
3Long-term Antibiotics for Treatment and Prevention of Otitis Media in Aborignal ChildrenCompletedNCT00539149Phase 4
4Effect of Prevnar 13 on Ear Infections in ChildrenCompletedNCT01199016Phase 4
5Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis MediaCompletedNCT00195611Phase 4
6Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in ChildrenCompletedNCT01082029Phase 4
7A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis MediaCompletedNCT00645112Phase 4
8A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis MediaCompletedNCT00644943Phase 4
9Postoperative Effects of Intranasal Fentanyl, IV and IM Morphine in Children Undergoing MyringotomyCompletedNCT01244126Phase 4
10Early Oseltamivir Treatment of Influenza in Children 1-3 Years of AgeCompletedNCT00593502Phase 4
11Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®)CompletedNCT00419380Phase 4
12Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.CompletedNCT01694108Phase 4
13Hutterite Influenza Prevention StudyCompletedNCT00877396Phase 4
14DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic EffectCompletedNCT00424905Phase 4
15The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in ChildrenRecruitingNCT00393159Phase 4
16Pneumococcal Vaccines Early and in CombinationRecruitingNCT01174849Phase 4
17Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in ChildrenRecruitingNCT02653742Phase 4
18Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics)RecruitingNCT01800747Phase 4
19Amoxicillin Clavulanate in Treatment of Acute Otitis MediaActive, not recruitingNCT00299455Phase 4
20Live Versus Inactivated Influenza Vaccine Study in Hutterite ChildrenActive, not recruitingNCT01653015Phase 4
21Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of LifeEnrolling by invitationNCT01735084Phase 4
22N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis MediaNot yet recruitingNCT00956748Phase 4
23Improving Otitis Media Care With Clinical Decision SupportCompletedNCT00581711Phase 3
24Xylitol Syrup for the Prevention of Acute Otitis Media in Otitis-prone ChildrenCompletedNCT01044030Phase 3
25Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in ChildrenCompletedNCT00781521Phase 3
26Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine SerotypesCompletedNCT00378417Phase 3
27A Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy TubesCompletedNCT00578474Phase 3
28Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis MediaCompletedNCT00051753Phase 3
29Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis MediaCompletedNCT00638534Phase 3
30Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis MediaCompletedNCT02044341Phase 3
31COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate VaccineCompletedNCT00466947Phase 3
32Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy TubesCompletedNCT00579189Phase 3
33Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in ChildrenCompletedNCT02541760Phase 3
34Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850ACompletedNCT00839254Phase 3
35Acute Otitis Media: Adjuvant Therapy to Improve OutcomeCompletedNCT00000363Phase 3
36Amoxicillin-clavulanate in Treating Acute Otitis Media Evaluated by Daily TympanometryCompletedNCT01244581Phase 3
37Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial FloraCompletedNCT01027494Phase 3
38Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis MediaCompletedNCT00645203Phase 2, Phase 3
39Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric PatientsCompletedNCT01404611Phase 3
40Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid SpraysCompletedNCT00279916Phase 3
41Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis MediaCompletedNCT00360100Phase 3
42Evaluation of the Tympanostomy Tube Delivery SystemCompletedNCT01202578Phase 2, Phase 3
43Clinical Study to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric PatientsCompletedNCT01395966Phase 3
44A Study of the Effectiness and Safety of Levofloxacin in Treating Children With a Rapid and Severe Onset of Infection and Inflammation of the Middle Ear That is Difficult to TreatCompletedNCT00044473Phase 3
45PneuMum: Pneumococcal Vaccination of Australian Indigenous MothersCompletedNCT00714064Phase 3
46A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear InfectionsCompletedNCT00643292Phase 3
47A Trial of Point of Care Information in Ambulatory PediatricsCompletedNCT00368823Phase 3
48ParentLink: Better and Safer Emergency Care for ChildrenCompletedNCT00457600Phase 2, Phase 3
49Open-Label Study of OTO-201 for Middle Ear Effusion Evaluating Trans-Tympanostomy Tube AdministrationCompletedNCT02350998Phase 3
50Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube PlacementCompletedNCT01188551Phase 2, Phase 3

Search NIH Clinical Center for Otitis Media

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: otitis media

Genetic Tests for Otitis Media

About this section

Anatomical Context for Otitis Media

About this section

MalaCards organs/tissues related to Otitis Media:

33
Lung, Breast, Bone, Endothelial, Tonsil, Brain, Heart

Animal Models for Otitis Media or affiliated genes

About this section

MGI Mouse Phenotypes related to Otitis Media:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.3ALB, CD40LG, CD79A, IL6, MBL2, TLR2
2MP:00020067.7ALB, CD79A, IL10, IL1B, IL6, MUC2
3MP:00053817.2ALB, FBXO11, IL10, IL6, MUC2, MUC5AC
4MP:00053976.4CCL11, CD40LG, CD79A, FBXO11, IL10, IL1B
5MP:00053765.8ALB, CD40LG, CD79A, FBXO11, IL10, IL1B
6MP:00053875.6CCL11, CD40LG, CD79A, FBXO11, IL10, IL1B

Publications for Otitis Media

About this section

Articles related to Otitis Media:

(show top 50)    (show all 1416)
idTitleAuthorsYear
1
Zinc lozenges and vitamin C for the common cold are not examples of placebo effect in action. (26071891)
2015
2
Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases. (25474496)
2014
3
VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival. (24814803)
2014
4
O-007a88stop the scanners! External validation of algorithms predicting complications in patients with Crohn's disease presenting to the emergency department. (25407198)
2014
5
Effect of recombinant Ganoderma lucidum immunoregulatory protein on cyclophosphamide-induced leukopenia in mice. (23656432)
2013
6
Complete decongestive therapy for treatment of lymphedema. (23375063)
2013
7
miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia. (22886504)
2012
8
Antibiotics administration before enema reduction of intussusception: is it necessary? (22595575)
2012
9
Initial experience with the 5 A9 300-mm Proteus embolic capture angioplasty balloon in the treatment of peripheral vascular disease. (23210883)
2012
10
You're the flight surgeon: nonarteritic ischemic optic neuropathy. (22764620)
2012
11
Predictors of velopharyngeal insufficiency after Le Fort I maxillary advancement in patients with cleft palate. (21783004)
2011
12
Pathophysiology of diabetes in elderly people. (20518191)
2010
13
Vertebral osteomyelitis and discitis with epidural abscess: an unusual finding ten weeks post open abdominal aortic aneurysm repair. (20336910)
2010
14
Sleep-related screaming as a manifestation of frontal lobe epilepsy in a 8 year-old girl: case report with diagnostic polysomnographic and neuroradiological findings. (20329598)
2009
15
Periosteal chondroma of the pediatric cervical spine. (19278317)
2009
16
Signaling pathway involved in hypoxia-inducible factor-1alpha regulation in hypoxic-ischemic cortical neurons in vitro. (19553016)
2009
17
Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response. (17882159)
2008
18
Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation into an ex vivo wound-healing model. (17898090)
2008
19
Serological survey on Aujeszky's disease, swine influenza and porcine reproductive and respiratory syndrome virus infections in Italian pigs. (19227130)
2008
20
Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast). (18242117)
2008
21
Carboxyl-terminal disulfide bond of acid sphingomyelinase is critical for its secretion and enzymatic function. (18052040)
2007
22
The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4. (17496063)
2007
23
Localization of the pH gate in Kir1.1 channels. (16891366)
2006
24
alphaV integrins are necessary for eutrophic inward remodeling of small arteries in hypertension. (16380536)
2006
25
A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice. (15863313)
2005
26
An experimental gingivitis study to evaluate the clinical effects of a stannous fluoride dentifrice. (16296255)
2004
27
Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells. (15297850)
2004
28
Plasma interleukin-12 in malaria-tolerant papua new guineans: inverse correlation with Plasmodium falciparum parasitemia and peripheral blood mononuclear cell nitric oxide synthase activity. (14573655)
2003
29
Chronic occupational mercury exposure in renal damage in workers in the chlorine-alkali electrolysis industry]. (14528721)
2003
30
The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. (14608905)
2003
31
Comparative studies of LFA-1/ICAM-1 interaction by micropipette and flow chamber techniques. (12454403)
2003
32
Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines. (12946570)
2003
33
Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. (12592259)
2003
34
Cytokine regulation of syndecan-1 and -2 gene expression in human periodontal fibroblasts and osteoblasts. (12200971)
2002
35
Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. (11978135)
2002
36
Human platelets activate porcine endothelial cells through a CD154-dependent pathway. (11740405)
2001
37
Chemokines in human periodontal disease tissues. (11472436)
2001
38
Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (10861320)
2000
39
Severe peripheral neuropathy, cardiac hypofunction, and syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in a patient with Churg-Strauss syndrome]. (10614173)
1999
40
Werdnig-Hoffmann disease. The first prenatal diagnosis in Cuba]. (10652743)
1999
41
Low cell motility induced by hsp27 overexpression decreases osteolytic bone metastases of human breast cancer cells in vivo. (10469286)
1999
42
Apoptosis versus proliferation activities and relative mechanism in chronic obstructive pulmonary disease]. (11038804)
1998
43
Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens. (9669297)
1998
44
The gene for human U2 snRNP auxiliary factor small 35-kDa subunit (U2AF1) maps to the progressive myoclonus epilepsy (EPM1) critical region on chromosome 21q22.3. (8660980)
1996
45
Involvement of interferon-gamma and tumor necrosis factor-alpha in host defense against Rhodococcus equi. (8501339)
1993
46
Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF. (7506580)
1993
47
Mechanisms of dentin sensitivity. (2197121)
1990
48
Molecular epidemiology of neonatal meningitis due to Citrobacter diversus: a study of isolates from hospitals in Maryland. (3734491)
1986
49
Chronic pyelonephritis: relative incidence in transplant recipients. (5330923)
1966
50

Variations for Otitis Media

About this section

Expression for genes affiliated with Otitis Media

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Otitis Media patients vs. healthy controls: 32
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1PNLIPRP3pancreatic lipase-related protein 3Blood-6.470.003
2FAM20Afamily with sequence similarity 20, member ABlood+3.090.015

Search GEO for disease gene expression data for Otitis Media.

Pathways for genes affiliated with Otitis Media

About this section

Pathways related to Otitis Media according to GeneCards Suite gene sharing:

(show all 46)
idSuper pathwaysScoreTop Affiliating Genes
19.6IL1B, IL6, TNF
2
Show member pathways
9.5CD40LG, CXCL8, TNF
39.5CXCL8, IL6, TNF
4
Show member pathways
9.5IL1B, RNASE3, TLR2, TLR4
59.4IL1B, TLR2, TLR4, TNF
6
Show member pathways
9.3IL1B, IL6, TLR2, TLR4
79.3IL6, TLR2, TLR4, TNF
89.3CXCL8, IL1B, IL6, RNASE3
9
Show member pathways
9.3MUC2, MUC5AC, MUC5B
109.3CCL11, CXCL8, IL6
11
Show member pathways
9.2CXCL8, IL1B, IL6, TNF
129.2CXCL8, IL1B, IL6, TNF
13
Show member pathways
9.2CXCL8, IL1B, IL6, TNF
149.2CD79A, IL10, IL6, TNF
159.2CCL11, CD40LG, IL10
169.1IL10, IL1B, IL6, TNF
179.1IL10, IL1B, IL6, TNF
189.1IL10, IL1B, IL6, TNF
19
Show member pathways
9.1IL6, MUC5AC, MUC5B, TLR2
20
Show member pathways
9.1CD40LG, IL1B, TLR2, TLR4, TNF
219.1IL6, RNASE3, TLR2, TLR4, TNF
229.0CD40LG, CXCL8, IL1B, TLR4, TNF
23
Show member pathways
8.9CXCL8, IL1B, IL6, TLR4, TNF
24
Show member pathways
8.9ALB, IL1B, IL6, TNF
258.8IL10, IL1B, IL6, TLR4, TNF
26
Show member pathways
8.8CXCL8, IL10, IL1B, IL6, TNF
278.8CXCL8, IL10, IL1B, IL6, TNF
288.7CXCL8, IL1B, IL6, TLR2, TLR4, TNF
298.7CXCL8, IL1B, IL6, TLR2, TLR4, TNF
308.7CXCL8, IL1B, IL6, MBL2, TLR4, TNF
31
Show member pathways
8.7CD40LG, IL1B, IL6, TLR2, TLR4, TNF
32
Show member pathways
8.6CD40LG, IL10, IL1B, TLR2, TLR4, TNF
33
Show member pathways
8.6IL10, IL1B, IL6, TLR2, TLR4, TNF
348.5CD40LG, IL10, IL6, TLR2, TLR4, TNF
35
Show member pathways
8.5CXCL8, IL1B, IL6, RNASE3, TLR2, TLR4
368.5CXCL8, IL10, IL1B, IL6, TLR4, TNF
378.4IL10, IL1B, IL6, RNASE3, TLR2, TLR4
38
Show member pathways
8.3IL10, IL1B, IL6, RNASE3, TLR2, TLR4
39
Show member pathways
8.2CCL11, CXCL8, IL1B, IL6, TLR2, TLR4
40
Show member pathways
8.0CXCL8, IL10, IL1B, IL6, RNASE3, TLR2
417.9CD40LG, CXCL8, IL10, IL1B, IL6, TLR2
427.9CXCL8, IL10, IL1B, IL6, MUC2, TLR2
43
Show member pathways
7.5CCL11, CD40LG, IL10, IL1B, IL6, RNASE3
44
Show member pathways
7.4ALB, CXCL8, IL10, IL1B, IL6, RNASE3
45
Show member pathways
7.3CXCL8, IL1B, IL6, MUC2, MUC5AC, MUC5B
46
Show member pathways
7.2CCL11, CD40LG, CXCL8, IL10, IL1B, IL6

GO Terms for genes affiliated with Otitis Media

About this section

Cellular components related to Otitis Media according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.5CD40LG, IL6, TLR4

Biological processes related to Otitis Media according to GeneCards Suite gene sharing:

(show all 41)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of calcidiol 1-monooxygenase activityGO:006055910.6IL1B, TNF
2positive regulation of membrane protein ectodomain proteolysisGO:005104410.6IL1B, TNF
3sequestering of triglycerideGO:003073010.6IL1B, TNF
4regulation of establishment of endothelial barrierGO:190314010.6IL1B, TNF
5positive regulation of chemokine biosynthetic processGO:004508010.6IL1B, TNF
6positive regulation of nitric-oxide synthase biosynthetic processGO:005177010.6TLR2, TLR4
7positive regulation of interleukin-8 biosynthetic processGO:004541610.6TLR4, TNF
8I-kappaB phosphorylationGO:000725210.5TLR2, TLR4
9positive regulation of fever generationGO:003162210.5IL1B, TNF
10negative regulation of lipid catabolic processGO:005099510.5IL1B, TNF
11epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.5IL6, TNF
12regulation of immunoglobulin secretionGO:005102310.5CD40LG, TNF
13regulation of I-kappaB kinase/NF-kappaB signalingGO:004312210.4IL1B, TNF
14receptor biosynthetic processGO:003280010.4IL10, TNF
15negative regulation of cytokine secretion involved in immune responseGO:000274010.4IL10, TNF
16negative regulation of lipid storageGO:001088810.3IL6, TNF
17positive regulation of chemokine productionGO:003272210.3TLR2, TLR4, TNF
18cellular response to lipoteichoic acidGO:007122310.3TLR2, TLR4
19positive regulation of NF-kappaB import into nucleusGO:004234610.3IL1B, TLR4, TNF
20positive regulation of nitric oxide biosynthetic processGO:004542910.2IL1B, IL6, TNF
21positive regulation of MHC class II biosynthetic processGO:004534810.2IL10, TLR4
22positive regulation of interferon-gamma productionGO:003272910.1IL1B, TLR4, TNF
23cellular response to hepatocyte growth factor stimulusGO:003572910.1IL10, IL6
24activation of MAPK activityGO:000018710.1IL1B, TLR4, TNF
25negative regulation of growth of symbiont in hostGO:004413010.1IL10, MBL2, TNF
26lipopolysaccharide-mediated signaling pathwayGO:003166310.0IL1B, TLR2, TLR4
27negative regulation of interleukin-6 productionGO:00327159.9IL10, TLR4, TNF
28positive regulation of apoptotic processGO:00430659.8IL1B, IL6, TNF
29positive regulation of inflammatory responseGO:00507299.8CCL11, TLR2, TLR4
30neutrophil chemotaxisGO:00305939.7CCL11, CXCL8, IL1B
31defense response to Gram-positive bacteriumGO:00508309.7IL6, MBL2, RNASE3, TLR2, TNF
32response to glucocorticoidGO:00513849.6IL10, IL1B, IL6, TNF
33positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.6IL10, IL1B, IL6, TNF
34positive regulation of interleukin-6 productionGO:00327559.5IL1B, IL6, TLR4, TNF
35positive regulation of NF-kappaB transcription factor activityGO:00510929.4CD40LG, IL1B, IL6, TNF
36defense response to bacteriumGO:00427429.2IL10, MBL2, TLR4, TNF
37response to organic substanceGO:00100339.1ALB, IL10, TNF
38cellular response to lipopolysaccharideGO:00712229.0CXCL8, IL1B, IL6, TLR4, TNF
39cellular response to tumor necrosis factorGO:00713569.0CCL11, CXCL8, IL6
40inflammatory responseGO:00069548.8CCL11, IL10, IL1B, IL6, TNF
41immune responseGO:00069557.9CCL11, CXCL8, IL10, IL1B, IL6, TLR2

Sources for Otitis Media

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet